TRCT
CELG

Tower Research Capital (TRC)’s Celgene Corp CELG Stock Holding History

Tower Research Capital (TRC)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,358
Closed -$830K – 4930
2019
Q3 		$830K Sell
8,358
-13,413
-62% -$1.27M 0.06% 350
2019
Q2 		$2.01M Buy
21,771
+9,331
+75% +$886K 0.14% 112
2019
Q1 		$1.17M Buy
12,440
+12,178
+4,648% +$1.07M 0.07% 227
2018
Q4 		$17K Sell
262
-11,839
-98% -$874K ﹤0.01% 2091
2018
Q3 		$1.08M Sell
12,101
-31,744
-72% -$2.81M 0.08% 186
2018
Q2 		$3.48M Buy
43,845
+43,647
+22,044% +$3.62M 0.2% 97
2018
Q1 		$18K Sell
198
-856
-81% -$82.2K ﹤0.01% 2236
2017
Q4 		$110K Sell
1,054
-2,383
-69% -$269K 0.01% 828
2017
Q3 		$501K Sell
3,437
-5,449
-61% -$742K 0.04% 257
2017
Q2 		$1.15M Buy
8,886
+8,866
+44,330% +$1.09M 0.13% 125
2017
Q1 		$2K Sell
20
-2,557
-99% -$306K ﹤0.01% 2749
2016
Q4 		$298K Buy
2,577
+1,761
+216% +$196K 0.03% 492
2016
Q3 		$85K Sell
816
-5,970
-88% -$646K 0.01% 882
2016
Q2 		$669K Buy
6,786
+3,650
+116% +$378K 0.06% 210
2016
Q1 		$314K Buy
3,136
+3,064
+4,256% +$315K 0.05% 238
2015
Q4 		$9K Sell
72
-2,032
-97% -$235K ﹤0.01% 2365
2015
Q3 		$228K Buy
2,104
+1,963
+1,392% +$244K 0.02% 261
2015
Q2 		$16K Sell
141
-846
-86% -$96.7K ﹤0.01% 2333
2015
Q1 		$114K Buy
987
+607
+160% +$72.5K 0.01% 782
2014
Q4 		$43K Sell
380
-14,836
-98% -$1.56M ﹤0.01% 1123
2014
Q3 		$1.44M Buy
15,216
+15,193
+66,057% +$1.37M 0.16% 122
2014
Q2 		$2K Sell
23
-53
-70% -$4.03K ﹤0.01% 3585
2014
Q1 		$5K Sell
76
-5,606
-99% -$444K ﹤0.01% 3380
2013
Q4 		$480K Sell
5,682
-35,164
-86% -$2.78M 0.08% 195
2013
Q3 		$3.15M Buy
40,846
+40,366
+8,410% +$2.83M 0.34% 61
2013
Q2 		$28K Buy
+480
New +$28.9K ﹤0.01% 1425

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Tower Research Capital (TRC)'s CELG Position: Q4 2019 in Review

Tower Research Capital (TRC) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,358 shares — an estimated $830K sold.

Tower Research Capital (TRC) first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.48M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Tower Research Capital (TRC) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 8,358 Celgene Corp shares in Q4 2019, an estimated $830K.
  • Tower Research Capital (TRC) first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Tower Research Capital (TRC)'s Celgene Corp position peaked at $3.48M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.